BSE Live
Feb 27, 15:40Prev. Close
8850.60
Open Price
8838.95
Bid Price (Qty.)
8611.00 (10)
Offer Price (Qty.)
8880.00 (1)
NSE Live
Feb 27, 15:56Prev. Close
8849.00
Open Price
8805.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
8849.00 (15)
| Key Financial Ratios of AstraZeneca Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -8.34 | -0.20 | -35.81 | 7.91 | 25.65 | |
| Diluted EPS (Rs.) | -8.34 | -0.20 | -35.81 | 7.91 | 25.65 | |
| Cash EPS (Rs.) | -2.22 | 3.85 | -30.90 | 10.84 | 29.18 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 60.30 | 68.64 | 39.90 | 75.71 | 71.88 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 60.30 | 68.64 | 39.90 | 75.71 | 71.88 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 3.50 | 10.00 | |
| Revenue from Operations/Share (Rs.) | 206.83 | 189.59 | 156.17 | 212.61 | 237.72 | |
| PBDIT/Share (Rs.) | -2.22 | -1.51 | -23.20 | 14.64 | 43.90 | |
| PBIT/Share (Rs.) | -8.34 | -5.56 | -28.11 | 11.70 | 40.38 | |
| PBT/Share (Rs.) | -8.34 | 0.00 | -28.11 | 11.70 | 40.38 | |
| Net Profit/Share (Rs.) | -8.34 | -0.20 | -35.81 | 7.91 | 25.65 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -1.07 | -0.79 | -14.85 | 6.88 | 18.46 | |
| PBIT Margin (%) | -4.03 | -2.93 | -17.99 | 5.50 | 16.98 | |
| PBT Margin (%) | -4.03 | 0.00 | -17.99 | 5.50 | 16.98 | |
| Net Profit Margin (%) | -4.03 | -0.10 | -22.93 | 3.71 | 10.79 | |
| Return on Networth / Equity (%) | -13.82 | -0.29 | -89.75 | 10.44 | 35.68 | |
| Return on Capital Employed (%) | -13.73 | -8.07 | -89.31 | 10.41 | 34.98 | |
| Return on Assets (%) | -5.06 | -0.12 | -29.24 | 5.77 | 20.77 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 125.62 | 114.04 | 127.54 | 155.37 | 192.53 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.01 | 1.12 | 0.80 | 1.30 | 1.75 | |
| Quick Ratio (X) | 0.68 | 0.73 | 0.39 | 0.80 | 1.29 | |
| Inventory Turnover Ratio (X) | 6.00 | 4.95 | 4.57 | 7.08 | 10.39 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 44.26 | 38.98 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 32.28 | 34.27 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 55.74 | 61.02 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 67.72 | 65.73 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,268.67 | 2,670.68 | 1,616.28 | 5,132.72 | 3,034.11 | |
| EV/Net Operating Revenue (X) | 4.39 | 5.63 | 4.14 | 9.66 | 5.11 | |
| EV/EBITDA (X) | -408.16 | -709.52 | -27.87 | 140.26 | 27.64 | |
| MarketCap/Net Operating Revenue (X) | 4.44 | 5.82 | 4.19 | 9.76 | 5.25 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 55.73 | 61.01 | |
| Price/BV (X) | 15.22 | 16.08 | 16.39 | 27.40 | 17.36 | |
| Price/Net Operating Revenue | 4.44 | 5.82 | 4.19 | 9.76 | 5.25 | |
| Earnings Yield | -0.01 | 0.00 | -0.05 | 0.00 | 0.02 |
12.02.2026
01.02.2026
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
10.11.2025
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
17.02.2025
AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y
21.11.2024
AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y